Statistical Analyses of Mutually Exclusive Competing Risks in Neonatal Studies
DOI:
https://doi.org/10.6000/1929-6029.2016.05.03.5Keywords:
Competing risk, randomized controlled trial, composite outcome, chi-square test, post-hoc testingAbstract
Following the well-established approach on how to deal with competing risks in the situation of time-to-event endpoints, cumulative incidences have to be used to analyse each single category of an outcome in the situation of competing risks without a time-to-event structure as well. This can be easily done by applying a simple chi-square test.
Nevertheless, these categorial outcomes are usually combined to get a composed dichotomous outcome to face the problem on how to deal with a significant chi-square omnibus test in the situation of more than 1 df, i.e. > 2x2 tables.
The aim of this report is to question the practice of combined, i.e. composed dichotomized, endpoints because important information is lost and the real effect of interest in confirmatory phase III studies may only become apparent in explorative secondary analyses.
It is shown – by using hypothetical data and by recalculation of published phase III studies’ results – how the use of a chi-square omnibus test and the scarcely known post-hoc testing answers the real question of interest within one primary confirmatory analysis. This method reveals insight into the actual effect of a new treatment or therapy on the event of interest in the presence of a mutually exclusive competing risk
References
Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695-706. http://dx.doi.org/10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O DOI: https://doi.org/10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
Cheng SC, Fine JB, Wei LJ. Prediction of cumulative incidence function under the proportional hazards model. Biometrics 1998; 54: 219-228. http://dx.doi.org/10.2307/2534009 DOI: https://doi.org/10.2307/2534009
Dignam JJ, Zhang Q, Kocherginsky M. The use and interpretation of competing risks regression models. Clin Cancer Res 2012; 18(8): 2301-2308. http://dx.doi.org/10.1158/1078-0432.CCR-11-2097 DOI: https://doi.org/10.1158/1078-0432.CCR-11-2097
Chappel R. Competing risk analyses: How are they different and why should you care? Clin Cancer Res 2012; 18(8): 2127-2129. http://dx.doi.org/10.1158/1078-0432.CCR-12-0455 DOI: https://doi.org/10.1158/1078-0432.CCR-12-0455
Schmoor C, Schumacher M, Finke J, Beyersmann J. Competing risks and multistate models. Clin Cancer Res 2013; 19(1): 12-21. http://dx.doi.org/10.1158/1078-0432.CCR-12-1619 DOI: https://doi.org/10.1158/1078-0432.CCR-12-1619
Spratt DE, Wu AJ, Adeseye V, et al. Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non-small-cell lung cancer: Implications for surveillance. Clin Lung Cancer 2015; Oct 1. pii: S1525-7304(15)00238-7. http://dx.doi.org/10.1016/j.cllc.2015.09.006 DOI: https://doi.org/10.1016/j.cllc.2015.09.006
Wulaningsih W, Vahdaninia M, Rowley M, et al. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis. BMC Cancer 2015; 15(913): 1-9. http://dx.doi.org/10.1186/s12885-015-1928-z DOI: https://doi.org/10.1186/s12885-015-1928-z
Turin TC, Okamura T, Afzahl AR, et al. Hypertension and lifetime risk of stroke. J Hypertens 2016; 34(1): 116-122. http://dx.doi.org/10.1097/HJH.0000000000000753 DOI: https://doi.org/10.1097/HJH.0000000000000753
Bassler D, Plavka R, Shinwell ES, et al. for the NEUROSIS Trial Group. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med 2015; 373: 1497-1456. http://dx.doi.org/10.1056/NEJMoa1501917 DOI: https://doi.org/10.1056/NEJMoa1501917
SUPPORT Study Group of the Eunice Kennedy shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362: 1970-1979. http://dx.doi.org/10.1056/NEJMoa0911783 DOI: https://doi.org/10.1056/NEJMoa0911783
SUPPORT Study Group of the Eunice Kennedy shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362: 1959-1969. http://dx.doi.org/10.1056/NEJMoa0911781 DOI: https://doi.org/10.1056/NEJMoa0911781
Shankaran S, Pappas A, McDonald SA, et al. for the Eunice Kennedy shriver NICHD Neonatal Research Network. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 2012; 366: 2085-2092. http://dx.doi.org/10.1056/NEJMoa1112066 DOI: https://doi.org/10.1056/NEJMoa1112066
Azzopardi D, Strohm B, Marlow N, et al. for the TOBY Study Group. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med 2014; 371: 140-149. http://dx.doi.org/10.1056/NEJMoa1315788 DOI: https://doi.org/10.1056/NEJMoa1315788
Mayo Clinic [homepage on the internet]. Locally written SAS macros (cited 2016 January 14): available from http://www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros
Mantel N, Haenszel W. Statistical Aspects of the Analysis of Data From Restrospective Studies of Disease. JNCI – J Natl Cancer Institute 1959; 22(4): 719-748.
Sharpe D. Your Chi-Square Test is Statistically Significant: Now What? Practical Assessment, Research & Evaluation 2015; 20(8). Available online: http://pareonline.net/ getvn.asp?v=20&n=8
Franke TM, Ho T, Christie ChA. The chi-square test: Often used and more often misinterpreted. Am J Eval 2012; 33(3): 448-458. http://dx.doi.org/10.1177/1098214011426594 DOI: https://doi.org/10.1177/1098214011426594
Agresti A. Categorical data analysis (3rd ed.). Hoboken NJ: Wiley 2013.
MacDonald PL, Gardner RC. Type I error rate comparisons of post hoc procedures for IxJ chi-square tables. Educ Psychol Meas 2000; 60(5): 735-754. http://dx.doi.org/10.1177/00131640021970871 DOI: https://doi.org/10.1177/00131640021970871
Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. NEJM 2006; 354: 2112-2121. http://dx.doi.org/10.1056/NEJMoa054065 DOI: https://doi.org/10.1056/NEJMoa054065
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 C. Engel, A.R. Franz
This work is licensed under a Creative Commons Attribution 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
